Tiziana Life Sciences (LON:TILS) Stock Price Passes Above 50-Day Moving Average – Time to Sell?

Tiziana Life Sciences PLC (LON:TILS)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 58.50 ($0.74) and traded as high as GBX 59 ($0.74). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.74), with a volume of 297,127 shares changing hands.

Tiziana Life Sciences Stock Performance

The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41. The business has a 50-day moving average of GBX 58.50 and a 200-day moving average of GBX 58.50. The company has a market capitalization of £113.85 million and a P/E ratio of -3.59.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.